Do you know about Obamacare and Cancer screenings?

While many Americans are confused about the Affordable Care Act (ACA) and how it will impact them, here is something we do know—all health insurance plans offered through the HealthCare.gov Marketplace must cover a list of 22 preventive health services for Women.

These services and are offered for women without charging a copayment when provided by an in-network provider through your health insurance.

Obamacare and cancer screenings and preventive counseling for women to help reduce your risk of cancer includes:

Breast Cancer Genetic Test Counseling (BRCA): This counseling is provided to help women who are at a greater risk of developing breast cancer through inherited genes known as BRCA1 and BRCA2. Harmful mutations found in these genes can be inherited from a person’s mother or father, and can significantly increase a woman’s risk of breast and ovarian cancer, as well as other types of cancer.

Breast Cancer Mammography Screenings: One of the most common cancer screenings for women, mammograms are x-ray pictures used to check for breast cancer in women who have no signs or symptoms of cancer. The National Cancer Institute recommends that women ages 40 and up have a breast cancer mammogram every 1 to 2 years.

Breast Cancer Chemoprevention Counseling: For women at a higher risk of breast cancer, this counseling service is available to find out more about preventive medications which can be taken to reduce their risk.

Cervical Cancer Screening: Cervical cancer screening tests (also known as a Pap test or Pap smear) are recommended for women ages 21 to 29 every 3 years and ages 30 to 65 every 5 years. These screenings have been critical in reducing the risk of cervical cancer in women and finding the disease in early stages to help cure it.

To help you answer more questions about the ACA, you can also read this understanding Obamacare article.

Have you scheduled preventive services through Obamacare and cancer screenings? Share your stories and comments below.

(Image via Cancer Research UK.)